Agilent Technologies Inc
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
99 / 240
Position in country
6451 / 14179
Return on Assets, %
11.4
-2.7
Net income margin, %
20.9
-6.7
EBITDA margin, %
27
5.6
Debt to Equity, %
41.2
15.1
Intangible assets and goodwill, %
40.2
4.7
Revenue CAGR 3Y, %
8.5
12.8
Total Equity change 1Y, %
10.3
-2.4
Revenue Y, % chg
-2.9
0
P/E
33.6
32.1
P/BV
6.6
2
P/S
6.1
4.1
EV/S
6.2
3.6
EV/EBITDA
21.9
7.8
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
6.5
48.9
Forward P/E
24.4
25.5
Dividend Yield, %
0.6
0.8
Forward Dividend Yield, %
0.7
0.2
Expected dividend per share
1
0
Payout Ratio, %
21.6
10.1
Dividend Ex Date
2024-04-01
Competitors
Ranks
-
IQVIA Holdings Inc
00%
-
West Pharmaceutical Services Inc
00%
-
Agilent Technologies Inc
00%
-
Avantor Inc
00%
-
Thermo Fisher Scientific Inc
00%
-
Danaher Corp
00%
-
Waters Corp
00%
-
Mettler-Toledo International Inc
00%
-
Revvity Inc
00%
-
Illumina Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Life Sciences Tools & Services
Sub-sector
Health Care
Capitalization (millions of $)
41241.6
Ticker
A.N
ISIN
US00846U1016
IPO date
1999-11-18
Availability on Russian exchanges
Yes
Reporting for
2024-03-05
Date fact. publication of reports
2024-01-31
Company Description
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. The Company’s business segments include life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. The life sciences and applied markets business segment provides application-focused solutions that include instruments and software. The Company's diagnostics and genomics business segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Company's Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: